CF BITES
BLOG

Original writing on CF research, treatment breakthroughs, community stories, and the science behind the mission.

Subscribe via RSS

Latest Post

Treatment

The Modulator Era: Where CF Treatment Stands Now

CFTR modulator therapy reshaped cystic fibrosis care for tens of thousands of patients. Here's where treatment stands in 2026, and who still isn't covered.

EB

August 27, 2026 · 2 min read

Read article →

All Articles

More from CF Bites

Research

Is There a Cure for Cystic Fibrosis Yet? Where Things Really Stand in 2026

The honest answer to the question every CF family gets asked. A plain-English look at CFTR modulators, gene therapy, and how close science actually is to a cure for cystic fibrosis in 2026.

Nicole Gordon·July 24, 2026·5 min readRead →
Treatment

ALYFTREK Is Here - And It Changes Everything for 95% of CF Patients

The FDA has approved expanded use of ALYFTREK and Trikafta, making CFTR modulator therapy available to approximately 95% of all people with cystic fibrosis in the United States. Here's what it means.

Nicole Gordon·April 25, 2026·5 min readRead →
Research

Yale Researchers May Have Found a Cure for CF - Before a Baby Is Even Born

In a landmark June 2025 study published in PNAS, Yale researchers used gene-editing nanoparticles to correct the CFTR mutation in mice before birth - durably, across multiple organs, into adulthood. The implications for human CF treatment are profound.

Nicole Gordon·April 22, 2026·6 min readRead →
Research

The 10% Problem: mRNA Therapy Targets the CF Patients Trikafta Can't Reach

Approximately 10% of people with cystic fibrosis have mutations where Trikafta doesn't work. mRNA therapy - the same technology behind COVID-19 vaccines - may be their best hope. Here's where the research stands.

Nicole Gordon·April 20, 2026·5 min readRead →
Research

Gene Therapy Breakthrough: 88% Chloride Function Restored for CF's Rarest, Hardest-to-Treat Mutations

A new nanoparticle-based CRISPR approach has restored 88–100% of chloride channel function in lab cells carrying the G542X mutation - one of the most severe CF mutations affecting patients current drugs can't reach.

Nicole Gordon·April 15, 2026·5 min readRead →
Research

Scientists Break Antibiotic Resistance in CF Lung Bacteria - A Major Step for Lung Disease

A study published in April 2026 discovered how to disable both individual antibiotic resistance and cross-protection between bacteria in CF patients' lungs, making previously untreatable infections vulnerable again.

Nicole Gordon·April 10, 2026·4 min readRead →
Community

From 2 Years to 61: How CF Life Expectancy Was Transformed - and Why the Fight Isn't Over

In the 1960s, a CF diagnosis meant a child was unlikely to reach school age. Today, the projected median survival is 61 years. This is the story of how science, community, and relentless fundraising rewrote the future of cystic fibrosis.

Nicole Gordon·April 5, 2026·6 min readRead →

The Team

Our Writers

Nicole Gordon

Nicole Gordon

Contributing Writer, CF Bites Foundation

View profile →

Taylor Lentz

Taylor Lentz

Founder, CF Bites Foundation

View profile →

Stay in the Loop

New articles posted regularly. Subscribe to get them in your RSS reader.

Subscribe via RSS